Cargando…

HER2 protein expression correlates with Lauren classification and P53 in gastric cancer patients

Human epidermal growth factor receptor 2 (HER2) is a key pathological characteristic of gastric cancer (GC). However, the clinical significance of HER2 expression in gastric carcinoma remains controversial. The purpose of this study was to analyze the clinicopathological characteristics of HER2 prot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chu, Yiming, Li, Hongbo, Wu, Dan, Guo, Qingqu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478214/ https://www.ncbi.nlm.nih.gov/pubmed/36123933 http://dx.doi.org/10.1097/MD.0000000000030647

Ejemplares similares

Lauren classification and individualized chemotherapy in gastric cancer
por: MA, JUNLI, et al.
Publicado: (2016)

Prognostic value of modified Lauren classification in gastric cancer
por: Ning, Fei-Long, et al.
Publicado: (2021)

High EpCAM expression is linked to proliferation and lauren classification in gastric cancer
por: Kroepil, Feride, et al.
Publicado: (2013)

Lauren classification combined with HER2 status is a better prognostic factor in Chinese gastric cancer patients
por: Qiu, Miaozhen, et al.
Publicado: (2014)

Cardia Gastric Cancer Is Associated With Increased PIK3CA Amplifications and HER2 Expression Than Noncardia Gastric Cancer According to Lauren Classification
por: Pai, Shih-Min, et al.
Publicado: (2021)

Comparison of HER2 and Lauren Classification between Biopsy and Surgical Resection Samples, Primary and Metastatic Samples of Gastric Cancer
por: Qiu, Miao-Zhen, et al.
Publicado: (2017)

Prognostic value and association of Lauren classification with VEGF and VEGFR-2 expression in gastric cancer
por: Li, Xiayi, et al.
Publicado: (2019)

Clinicopathological characteristics and prognostic analysis of Lauren classification in gastric adenocarcinoma in China
por: Qiu, Miao-zhen, et al.
Publicado: (2013)

Intratumoral and peritumoral radiomics analysis for preoperative Lauren classification in gastric cancer
por: Wang, Xiao-Xiao, et al.
Publicado: (2020)

Clinical Relevance of the Tumor Location-Modified Lauren Classification System of Gastric Cancer
por: Choi, Jang Kyu, et al.
Publicado: (2015)

Prognostic significance of serum inflammation indexes in different Lauren classification of gastric cancer
por: Yin, Xin, et al.
Publicado: (2021)

Double contrast-enhanced ultrasonography evaluation of preoperative Lauren classification of advanced gastric carcinoma
por: Huang, Pintong, et al.
Publicado: (2011)

ASO Author Reflections: Consideration of a Modified Classification System for Gastric Cancer Based on Lauren Subtypes
por: Zhao, Lin-Yong, et al.
Publicado: (2018)

Treatment of Locally Advanced Gastric Cancer (LAGC): Back to Lauren’s Classification in Pan–Cancer Analysis Era?
por: Zurlo, Ina Valeria, et al.
Publicado: (2020)

Clinical Relevance of the Tumor Location-Modified Laurén Classification System for Gastric Cancer in a Western Population
por: Moore, J. L., et al.
Publicado: (2022)

Superiority of Tumor Location-Modified Lauren Classification System for Gastric Cancer: A Multi-Institutional Validation Analysis
por: Zhao, Lin-Yong, et al.
Publicado: (2018)

Association Between DCE-MRI Perfusion Histogram Parameters and EGFR and VEGF Expressions in Different Lauren Classifications of Advanced Gastric Cancer
por: Li, Zhiheng, et al.
Publicado: (2022)

Mesenteric fibromatosis after resection for gastrointestinal stromal tumor of stomach: A case report
por: Chu, Yiming, et al.
Publicado: (2017)

Dickkopf-related protein 3 alters aerobic glycolysis in pancreatic cancer BxPC-3 cells, promoting CD4(+) T-cell activation and function
por: Guo, Qingqu, et al.
Publicado: (2021)

Distinct molecular subtypes of gastric cancer: from Laurén to molecular pathology
por: Cisło, Magdalena, et al.
Publicado: (2018)

Analysis of the Incidence and Survival of Gastric Cancer Based on the Lauren Classification: A Large Population-Based Study Using SEER
por: Tang, Chao-Tao, et al.
Publicado: (2020)

Preoperative prediction of Lauren classification in gastric cancer: a radiomics model based on dual-energy CT iodine map
por: Li, Min, et al.
Publicado: (2023)

Protective Effects of Female Reproductive Factors on Lauren Intestinal-Type Gastric Adenocarcinoma
por: Kim, Su Mi, et al.
Publicado: (2018)

Fusobacterium nucleatum is associated with worse prognosis in Lauren’s diffuse type gastric cancer patients
por: Boehm, Ellen Teresa, et al.
Publicado: (2020)

LMOD1, an oncogene associated with Lauren classification, regulates the metastasis of gastric cancer cells through the FAK-AKT/mTOR pathway
por: Tan, Yuen, et al.
Publicado: (2022)

Differential prognostic implications of gastric adenocarcinoma based on Lauren’s classification: a Surveillance, Epidemiology, and End Results (SEER)-based cohort study
por: Tang, Dehua, et al.
Publicado: (2021)

De-Ubiquitinating Enzymes USP21 Regulate MAPK1 Expression by Binding to Transcription Factor GATA3 to Regulate Tumor Growth and Cell Stemness of Gastric Cancer
por: Guo, Qingqu, et al.
Publicado: (2021)

Lauren Melissa Osojnak - BLV2022 - Talk in CDS
por: Osojnak, Lauren Melissa
Publicado: (2022)

First person – Lauren Brilli Skvarca and Hwa Han
Publicado: (2019)

Depletion of C12orf48 inhibits gastric cancer growth and metastasis via up-regulating Poly r(C)-Binding Protein (PCBP) 1
por: Lin, Lele, et al.
Publicado: (2022)

Android wireless application development: by Shane Conder, Lauren Darcey.
por: Conder, Shane, et al.
Publicado: (2009)

Correlation of HER2 With p53 and p63 in Urothelial Bladder Carcinoma
por: Ponnaboina, Divya Madhuri, et al.
Publicado: (2023)

Clinical Significance of p53 Protein Expression, Beta-catenin Expression and HER2 Expression for Epstein-Barr Virus-associated Gastric Cancer
por: Baek, Dong Won, et al.
Publicado: (2017)

Genome-Scale Metabolic Model Analysis of Metabolic Differences between Lauren Diffuse and Intestinal Subtypes in Gastric Cancer
por: Nam, Seungyoon, et al.
Publicado: (2022)

The Efficacy of Taxanes- and Oxaliplatin-Based Chemotherapy in the Treatment of Gastric Cancer After D2 Gastrectomy for Different Lauren Types
por: Zheng, Zhen, et al.
Publicado: (2016)

Effects of Reproductive Factors on Lauren Intestinal-Type Gastric Cancers in Females: A Multicenter Retrospective Study in South Korea
por: Jung, Yoon Ju, et al.
Publicado: (2022)

α2,3 sialic acid processing enzymes expression in gastric cancer tissues reveals that ST3Gal3 but not Neu3 are associated with Lauren's classification, angiolymphatic invasion and histological grade
por: Quirino, Michael W.L., et al.
Publicado: (2022)

Significance of Lauren Classification in Patients Undergoing Neoadjuvant/Perioperative Chemotherapy for Locally Advanced Gastric or Gastroesophageal Junction Cancers—Analysis from a Large Single Center Cohort in Germany
por: Schirren, Rebekka, et al.
Publicado: (2021)

The Correlation Between Mutant p53 Protein Expression and Cell Atypia in Early Differentiated Gastric Adenocarcinoma
por: Tang, Ming, et al.
Publicado: (2021)

A cohort study and meta-analysis of the evidence for consideration of Lauren subtype when prescribing adjuvant or palliative chemotherapy for gastric cancer
por: Wang, Kunning, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_12ch4beqg77ctjmdop3rc1e07l